Comparison of interferon-γ release assay and tuberculin test for screening in healthcare workers

Torres Costa, José; Silva, Rui; Sá, Raul; João Cardoso, Maria; Ribeiro, Carla; Nienhaus, Albert

doi:10.1016/S2173-5115(10)70031-2

Article information

Abstract

Healthcare workers (HCWs) have an increased risk of tuberculosis (TB). Screening for latent tuberculosis infection and active TB is therefore essential in infection control programs. Tuberculin skin test (TST) and Interferon-γ Release Assay (IGRA) were used simultaneously in 1686 HCWs between May 2007 and April 2009. A chest X-ray was performed in order to exclude active TB when TST was≥10mm or IGRA was positive and in HCWs with TB contact or symptoms. IGRA was positive in 33.1% and TST was>10mm in 78.3% of the HCWs. The proportion of positive IGRA results increased with the TST diameter. In those with a TST>15mm, 49.2% were IGRA positive. TST was more than twice as often positive than the IGRA. Therefore, TST+/IGRA-results were more often observed than concordant negative or positive results. In none of the HCWs with a TST+/IGRA-result active TB was diagnosed during the study period. Repeated BCG vaccination increased the number of TST+/IGRA-discordance. The smaller the interval after BCG vaccination, the higher was the TST+/IGRA-discordance.

In the screened HCWs population, active TB was diagnosed in 9. At the time of diagnosis TST and IGRA were positive in all active TB cases. The study period covers 24 months, therefore the average annual incidence rate was 268/100 000.

TB burden in HCWs in Portugal is high. Considering the limitations that TST and IGRA present, the best solution seems to be the use of both, using the IGRA higher specificity for confirming a positive TST, taking advantage of the best characteristics of each test.

Key-words:

Tuberculosis

healthcare workers

tuberculin skin test

interferon-γ release assay

Portugal

Resumo

Os profissionais de saúde (PS) têm um risco aumentado de tuberculose. O rastreio da tuberculose latente e da tuberculose activa é portanto essencial nos programas de controlo de infecção. Entre Maio de 2007 e Abril de 2009, foram utilizados simultaneamente a prova de tuberculina (PT) e o teste de libertação do interferão-γ (IGRA) em 1686 PS. Quando PT≥10mm ou IGRA positivo, e em PS com contacto com tuberculose ou sintomáticos, foi realizada uma radiografia torácica para excluir tuberculose activa. O IGRA foi positivo em 33,1% e a PT foi>10mm em 78.3% dos PS. A proporção de resultados IGRA positivos aumentou com o diâmetro da PT. Nos PS com PT>15mm, 49.2% são IGRA positivos. A PT foi positiva em mais do dobro dos casos do IGRA. Assim, foram observados mais frequentemente resultados PT+/IGRA-do que resultados concordantes negativos ou positivos. Em nenhum PS com resultado PT+/IGRA-foi diagnosticada tuberculose activa durante o período do estudo. A vacinação repetida pelo BCG aumentou o número de casos discordantes PT+/IGRA-. Quanto menor o intervalo após a vacinação pelo BCG, maior a discordância PT+/IGRA-.

Na população de PS rastreada, foram diagnosticados 9 casos de tuberculose activa, sendo todos PT e IGRA positivos na altura do diagnóstico. Este estudo durou 24 meses, pelo que a taxa de incidência anual média foi de 268/100 000.

A tuberculose é um problema importante nos PS em Portugal. Considerando as limitações que a PT e IGRA apresentam, a melhor solução parece ser o uso de ambos, utilizando a maior especificidade do IGRA para confirmar uma PT positiva, aproveitando as melhores características de cada teste.

Palavras-chave:

Tuberculose

profissionais de saúde

prova de tuberculina

teste de libertação do interferão-γ

Portugal

Full text is only aviable in PDF

Bibliography

[1.]

S. Saleiro, A.R. Santos, O. Vidal, T. Carvalho, J. Torres Costa, J.A. Marques.

Tuberculosis in hospital department health care workers.

Rev Port Pneumol, 13 (2007), pp. 789-799

Medline

[2.]

A. Seidler, A. Nienhaus, R. Diel.

Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas.

Respiration, 72 (2005), pp. 431-446

http://dx.doi.org/10.1159/000086261 | Medline

[3.]

D. Menzies, R. Joshi, M. Pai.

Risk of tuberculosis infection and disease associated with work in health care settings.

Int J Tuberc Lung Dis, 11 (2007), pp. 593-605

Medline

[4.]

CDC – Center for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Healthcare Settings, 2005. MMWR 2005; 54(RR-17):1–141.

[5.]

D. Menzies.

What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us?.

Clin infect Dis, 31 (2000), pp. S71-S74

http://dx.doi.org/10.1086/314075 | Medline

[6.]

P. Andersen, M.E. Munk, J.M. Pollock, T.M. Doherty.

Specific immune-based diagnosis of tuberculosis.

Lancet, 356 (2000), pp. 1099-1104

Medline

[7.]

P. Nahid, M. Pai, P.C. Hopewell.

Advances in the diagnosis and treatment of tuberculosis.

Proc Am Thorac Soc, 3 (2006), pp. 103-110

http://dx.doi.org/10.1513/pats.200511-119JH | Medline

[8.]

M. Pai, L.W. Riley, J.M. Colford.

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

Lancet Infect Dis, 4 (2004), pp. 761-776

http://dx.doi.org/10.1016/S1473-3099(04)01206-X | Medline

[9.]

D. Menzies, M. Pai, G. Comstock.

Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research.

Ann Intern Med, 146 (2007), pp. 340-352

Medline

[10.]

R. Diel, R. Loddenkemper, K. Meywald-Walter, S. Niemann, A. Nienhaus.

Predictive value of a whole blood IFN-{gamma} assay for the development of active TB disease.

Am J Respir Crit Care Med, 177 (2008), pp. 1164-1170

http://dx.doi.org/10.1164/rccm.200711-1613OC | Medline

[11.]

N. Harada, Y. Nakajima, K. Higuchi, Y. Sekiya, J. Rothel, T. Mori.

Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers.

Infection Control and Hospital Epidemiology, 27 (2006), pp. 442-448

http://dx.doi.org/10.1086/504358 | Medline

[12.]

B. Soberg, A.B. Andersen, H.K. Larsen, K. Weldingh, P. Andersen, K. Kofoerd, P. Ravn.

Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific INF-γ whole-blood test.

Scandinavian Journal of Infectious Diseases, 39 (2007), pp. 554-559

http://dx.doi.org/10.1080/00365540601148483 | Medline

[13.]

Y. Kobashi, Y. Obase, M. Fukuda, K. Yoshida, N. Miyashita, M. Fujii, M. Oka.

Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers.

Intern Med, 46 (2007), pp. 1543-1549

Medline

[14.]

V. Mirtskhulava, R. Kempker, K.L. Shields, M.K. Leonard, T. Tsertsvadze, C. del Rio, A. Salakaia, H.M. Blumberg.

Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia.

Int J Tuberc Lung Dis, 12 (2008), pp. 513-519

Medline

[15.]

A. Nienhaus, A. Schablon, B. Siano, C. le Bacle, R. Diel.

Evaluation of the interferon-gamma release assay in healthcare workers.

Int Arch Occup Environ Health, 81 (2008), pp. 295-300

http://dx.doi.org/10.1007/s00420-007-0212-1 | Medline

[16.]

A. Schablon, G. Beckmann, M. Harling, R. Diel, A. Nienhaus.

Prevalence of latent tuberculosis infection among healthcare workers in a hospital for pulmonary diseases.

J Occup Med Toxicol, 4 (2009), pp. 1

http://dx.doi.org/10.1186/1745-6673-4-1 | Medline

[17.]

P. Vinton, S. Mihrshahi, P. Johnson, G.A. Jenkin, D. Jolley, B.A. Biggs.

Comparison of QuantiFERON-TB gold in-tube test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.

Infection Control and Hospital Epidemiology, 30 (2009),

[18.]

Programa Nacional de Vacinação. Direcção-Geral de Saúde – Ministério da Saúde. Available at http://www.dgsaude.pt/upload/membro.id/ficheiros/i007442.pdf(accessed May 1st, 2009)

[19.]

D. Hosmer, S. Lemeshow.

Applied logistic regression.

John Wiley & Sons, (2000),

[20.]

M. Farhat, Greenaway, M. Pai, D. Menzies.

Falsepositive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?.

Int J Tuberc Lung Dis, 10 (2006), pp. 1192-1204

Medline

[21.]

A. Nienhaus, A. Schablon, R. Diel.

Interferon-γ release assay for the diagnosis of latent TB infection – analysis of discordant results, when compared to the tuberculin skin test.

PLoS ONE, 3 (2008), pp. e2665

http://dx.doi.org/10.1371/journal.pone.0002665 | Medline

[22.]

J. Torres Costa, R. Sá, M.J. Cardoso, R. Silva, J. Ferreira, C. Ribeiro, M. Miranda, J.L. Plácido, A. Nienhaus.

Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-γ release assay.

Eur Respir J, 34 (2009), pp. 1423-1428

http://dx.doi.org/10.1183/09031936.00053809 | Medline

[23.]

R. Diel, A. Seidler, A. Nienhaus, S. Rusch-Gerdes, S. Niemann.

Occupational risk of tuberculosis transmission in a low incidence area.

Respir Res, 6 (2005), pp. 35-45

http://dx.doi.org/10.1186/1465-9921-6-35 | Medline

[24.]

G. De Vries, M.M. Sebek, C.S. Lambregts-van Weezenbeek.

Health-care workers with tuberculosis infected during work.

Eur Respir J, 28 (2006), pp. 1216-1221

http://dx.doi.org/10.1183/09031936.06.00039906 | Medline

[25.]

S.-J. Lee S, Y.-C. Liu, T.-S. Huang, Y.-S. Chen, H.-C. Tsai, S.-R. Wann, H.-H. Lin.

Comparison of the interferon-γ release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.

Scandinavian Journal of Infectious Disease, 40 (2008), pp. 373-380

[26.]

D. Menzies.

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.

Am J Respir Crit Care Med, 159 (1999), pp. 15-21

http://dx.doi.org/10.1164/ajrccm.159.1.9801120 | Medline

[27.]

M. Pai, R. Joshi, S. Dogra, A.A. Zwerling, D. Gajalakshmi, K. Goswami, M.V.R. Reddy, S. Kalantri, P.C. Hill, D. Menzies, P.C. Hopewell.

T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India.

Int J Tuberc Lung Dis, 13 (2009), pp. 84-92

Medline

[28.]

Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in healthcare workers using repeated interferon-γ assays. Epidemiol Infect 2009.(ahead of print).

[29.]

U. Mack, G.B. Migliori, M. Sester, H.L. Rieder, S. Ehlers, D. Goletti, et al.

for the TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis?. – A TBNET consensus statement.

Eur Respir J, 33 (2009), pp. 956-973

http://dx.doi.org/10.1183/09031936.00120908 | Medline

[30.]

R. Duarte.

Teste tuberculínico. Como optimizar?.

Rev Port Pneumol, 15 (2009), pp. 295-304

Medline

[31.]

R. Duarte, J. Amado, H. Lucas, J.M. Sapage.

Comissão de Trabalho de Tuberculose da Sociedade Portuguesa de Pneumologia. Tratamento da tuberculose latente: Revisão das normas, 2006.

Rev Port Pneumol, 13 (2007), pp. 397-418

Medline

[32.]

M. Pai, R. Joshi, S. Dogra, D.K. Mendiratta, P. Narang, K. Dheda, S. Kalantri.

Persistently elevated T cell interferon-γ response after treatment for latent tuberculosis infection among healthcare workers in India: a preliminary report.

Journal of Occupational Medicine and Toxicology, 1 (2006), pp. 7

http://dx.doi.org/10.1186/1745-6673-1-7Article | Medline

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter